HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.
about
Virus like particle-based vaccines against emerging infectious disease viruses.Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesChimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.Virus-mimetic nanovesicles as a versatile antigen-delivery system.Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.Insect cells as a production platform of complex virus-like particles.Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.Justification for the inclusion of Gag in HIV vaccine candidates.Optimized expression of the antimicrobial protein Gloverin from Galleria mellonella using stably transformed Drosophila melanogaster S2 cells.Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.Impact of recombinant Drosophila S2 cell population enrichment on expression of rabies virus glycoprotein.Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in miceSingle-cell cloning enables the selection of more productive Drosophila melanogaster S2 cells for recombinant protein expression.Production of complex virus-like particles in insect cells
P2860
Q30249025-AF6CD868-2E06-4B16-98F5-7DCED298CBC3Q30353580-EED7DC63-2DCC-42B2-8CF3-CD2098FF2F74Q33683203-9862BDA2-731B-4331-AF8A-7E46C0D8CEBCQ35232804-3FC8C4F7-1A9F-47E9-A460-4D41D4E035D5Q36300220-CF57D375-43BE-4819-9B44-A041D9AB5754Q37415463-CC1372FA-123B-48E8-B3D8-51851D775820Q38072056-FA7D2037-0240-43E3-8F06-D2F441C1FA01Q38081976-8E208278-916A-45F9-A4C4-14A67469BC7EQ38177170-5DBBB4B6-3793-4332-B1A5-39DD93EBF041Q38662319-9F136404-4229-4991-BB96-FB49A6CD53F6Q38718931-E669025E-81EB-4661-B2B4-687DECFCC657Q38731982-E2C5AB9B-07BB-413F-A86F-EC62D94C5221Q40740103-4E9A8D33-7FF2-486B-B799-5EFA40DE3546Q42628113-1B853441-1BAB-4EAF-91AC-E7C56866F6F6Q55611484-90CFE873-886E-4A56-B87C-30F9C891EBAEQ58753726-7455C80A-9578-4CDC-A7ED-7DED8F3B51E1
P2860
HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@ast
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@en
type
label
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@ast
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@en
prefLabel
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@ast
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@en
P2093
P2860
P356
P1433
P1476
HIV-1 virus-like particles pro ...... a desirable vaccine component.
@en
P2093
Jingjing Liu
Lifei Yang
Xiaomin Li
Xiaoxing Huang
Yufeng Song
P2860
P304
P356
10.1128/JVI.07164-11
P407
P577
2012-05-02T00:00:00Z